Patterns of Relapse or Progression After Bortezomib-Based Salvage Therapy in Patients With Relapsed/Refractory Multiple Myeloma.

CONCLUSION: MM patients who relapsed or progressed as the transformed pattern for bortezomib-based salvage therapy have an extremely poor prognosis and might require new innovative approaches. PMID: 24630919 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/24630919?dopt=Abstract

Source: Clinical Lymphoma and Myeloma - February 18, 2014 Category: Cancer & Oncology Authors: Ahn JS, Jung SH, Yang DH, Bae SY, Kim YK, Kim HJ, Lee JJ Tags: Clin Lymphoma Myeloma Leuk Source Type: research